Catherine Coste - Dec 7, 2023 Form 4 Insider Report for BIOMERICA INC (BMRA)

Role
Director
Signature
/s/ Catherine Coste
Stock symbol
BMRA
Transactions as of
Dec 7, 2023
Transactions value $
$0
Form type
4
Date filed
12/11/2023, 05:18 PM
Previous filing
Nov 22, 2023
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BMRA Common stock 43.8K Dec 7, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRA Non-qualified stock option Award +32K 32K Apr 20, 2023 Common Stock 32K $1.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted to Ms. Coste in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023.
F2 Not Applicable